ANI eyes more deals to follow WellSpring
Executive Summary
ANI Pharmaceuticals is looking for further deals to accompany the US firm’s organic growth, according to president and chief executive Arthur Przybyl. In August, ANI acquired for US$18 million Canada-based WellSpring Pharma Services, in a bid to expand its contract manufacturing and development business, and to increase the US firm’s capacity to re-commercialise its pipeline of ANDAs that require a technology transfer from its local Baudette facility in Minnesota (Generics bulletin, 31 August 2018, page 14).
You may also be interested in...
Finance Watch: Recent Offerings Show Some Companies Were Ready For The Government Shutdown
Public Company Edition: The usual mid-January surge in public offerings hasn't happened this year, since the SEC can't process new filings, but Alnylam, Acceleron and others apparently were prepared for a lengthy shutdown. Also, ARM reports cell and gene therapy financing data.
Biden Launches Effort To Strengthen US Pharmaceutical Supply Chain
Executive order calls for short-term and long-term study, broad consultation, coordination with allies.
Cosmetic And Personal Care Trademark Review 23 February, 2021
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: